Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (43 quarters reported)
$399M in Q1 2016 → $909M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Praxis Precision Medicines | 8.7% | Unchanged | 271,116 | $79M |
| Trevi Therapeutics Inc | 6.7% | Trimmed 17% | 4,229,683 | $60.6M |
| Erasca Inc | 6.5% | Trimmed 2.6% | 4,020,619 | $58.9M |
| Arrivent Biopharma Inc | 6.0% | Added 6.2% | 1,787,104 | $54.1M |
| AS Abivax Sa | 4.5% | Unchanged | 414,899 | $41.1M |
| Entera Bio Ltd | 3.9% | New | 12,254,901 | $35.7M |
| Aclaris Therapeutics Inc | 3.9% | Unchanged | 6,694,637 | $35.2M |
| Alto Neuroscience Inc | 3.8% | Added 12% | 1,359,915 | $34.7M |
| Tango Therapeutics Inc | 3.8% | Unchanged | 1,379,769 | $34.4M |
| Corvus Pharmaceuticals Inc | 3.6% | Unchanged | 2,805,816 | $32.3M |
| Lb Pharmaceuticals Inc | 3.4% | Unchanged | 800,000 | $30.7M |
| Korsana Biosciences Inc | 3.1% | New | 877,020 | $28.1M |
| BT Blossomhill Therapeutics Inc | 3.1% | New | 1,493,740 | $27.8M |
| Faeth Therapeutics Inc | 2.8% | Added 17% | 844,576 | $25.1M |
| Camp4 Therapeutics Corporation | 2.5% | Added 31% | 5,584,111 | $22.6M |
| AL Achieve Life Science Inc | 2.4% | Unchanged | 2,751,032 | $22.3M |
| Sab Biotherapeutics Inc | 2.4% | Trimmed 5.3% | 6,915,011 | $21.9M |
| DT Dbv Technologies Sa | 2.4% | Unchanged | 1,844,758 | $21.7M |
| Bright Minds Biosciences Inc | 2.3% | Trimmed 25% | 417,879 | $20.8M |
| Design Therapeutics Inc | 2.2% | Unchanged | 1,612,903 | $20.3M |
| An2 Therapeutics Inc | 1.8% | Unchanged | 3,153,640 | $16.8M |
| Moonlake Immunotherapeutics | 1.8% | Unchanged | 1,400,000 | $16.4M |
| Minerva Neurosciences Inc | 1.6% | Unchanged | 4,322,747 | $14.5M |
| Odyssey Therapeutics Inc | 1.4% | Unchanged | 575,000 | $12.8M |
| Oric Pharmaceuticals Inc | 1.4% | Trimmed 50% | 924,392 | $12.5M |
| Eupraxia Pharmaceuticals Inc | 1.4% | Unchanged | 1,350,000 | $12.3M |
| Vor Biopharma Inc | 1.2% | New | 550,358 | $10.5M |
| Editas Medicine Inc | 1.0% | Unchanged | 3,555,250 | $9.14M |
| Surrozen Inc | 0.9% | Unchanged | 260,000 | $8.37M |
| Dyne Therapeutics Inc | 0.9% | Trimmed 67% | 514,402 | $8.29M |
| Aura Biosciences Inc | 0.8% | Unchanged | 1,166,667 | $7.33M |
| Cue Biopharma Inc | 0.8% | New | 280,057 | $7.25M |
| Monopar Therapeutics Inc | 0.8% | Unchanged | 90,500 | $7.21M |
| Satellos Bioscience Inc | 0.8% | Unchanged | 813,666 | $6.92M |
| Olema Pharmaceuticals Inc | 0.6% | Unchanged | 671,843 | $5.8M |
| Pepgen Inc | 0.6% | Unchanged | 2,325,000 | $5.63M |
| Onkure Therapeutics Inc | 0.6% | Unchanged | 1,927,710 | $5.25M |
| AT Attovia Therapeutics Inc | 0.6% | New | 300,000 | $5.14M |
| Adarx Pharmaceuticals Inc | 0.6% | New | 255,158 | $5.09M |
| Tenax Therapeutics Inc | 0.5% | Unchanged | 2,500,000 | $4.73M |
| Valneva Se | 0.5% | Unchanged | 763,199 | $4.72M |
| Avalo Therapeutics Inc | 0.5% | Unchanged | 275,000 | $4.22M |
| Compass Therapeutics Inc | 0.4% | Trimmed 56% | 3,423,547 | $3.56M |
| Sera Prognostics Inc | 0.4% | Unchanged | 1,650,440 | $3.45M |
| Instil Bio Inc | 0.2% | Unchanged | 292,743 | $2.12M |
| Inmed Pharmaceuticals Inc | 0.1% | Added 3.3% | 824,874 | $1.12M |
| Bolt Biotherapeutics Inc | 0.0% | Unchanged | 72,414 | $266K |
| Pasithea Therapeutics Corp | 0.0% | Trimmed 20% | 372,796 | $184K |
| Precision Biosciences Inc | 0.0% | Unchanged | 4,675 | $29.3K |
| Jasper Therapeutics Inc | 0.0% | New | 5,364 | $3.69K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SB Sinovac Biotech Ltd. | Exited | −5,903,000 | −$38.2M | — |
| Entera Bio Ltd | New | +12,254,901 | +$35.7M | 3.9% |
| Dianthus Therapeutics Inc | Exited | −353,998 | −$34.5M | — |
| Korsana Biosciences Inc | New | +877,020 | +$28.1M | 3.1% |
| BT Blossomhill Therapeutics Inc | New | +1,493,740 | +$27.8M | 3.1% |
| Dyne Therapeutics Inc | Trimmed | −1,043,064 | −$16.8M | 0.9% |
| Oric Pharmaceuticals Inc | Trimmed | −924,394 | −$12.5M | 1.4% |
| Trevi Therapeutics Inc | Trimmed | −864,985 | −$12.4M | 6.7% |
| Geron Corp | Exited | −8,671,797 | −$11.1M | — |
| Vor Biopharma Inc | New | +550,358 | +$10.5M | 1.2% |
Showing the 10 largest of 26 changes.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Erasca Inc | Trimmed | −8,024,068 | −$147M | 6.9% |
| Terns Pharmaceuticals Inc | Exited | −1,334,418 | −$70.4M | — |
| Tenax Therapeutics Inc | Added | +2,291,667 | +$33.3M | 3.3% |
| Arrivent Biopharma Inc | Added | +796,181 | +$27.7M | 5.3% |
| Tango Therapeutics Inc | Trimmed | −775,011 | −$24.2M | 3.9% |
| AS Abivax Sa - ADR | Added | +175,360 | +$23.4M | 5.0% |
| Praxis Precision Medicines | Trimmed | −67,779 | −$22.7M | 8.3% |
| Veradermics Inc | Exited | −300,000 | −$18.9M | — |
| Achieve Life Sciences Inc. | New | +2,751,032 | +$18M | 1.6% |
| Cogent Biosciences Inc | Exited | −422,300 | −$16.3M | — |
Showing the 10 largest of 27 changes.
quarter ended March 31, 2026 · filed May 20, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Trimmed | −4,012,510 | −$212M | 5.8% |
| Cidara Therapeutics, Inc. | Exited | −956,670 | −$211M | — |
| Cogent Biosciences Inc | Trimmed | −1,976,693 | −$76.1M | 1.4% |
| AP Avadel Pharmaceuticals PLC | Exited | −2,684,109 | −$57.8M | — |
| Erasca Inc | Added | +2,878,052 | +$46.6M | 16.3% |
| Zenas Biopharma Inc | Exited | −853,495 | −$31M | — |
| Geron Corp | Trimmed | −18,553,495 | −$27.6M | 1.1% |
| Sensei Biotherapeutics Inc | New | +722,020 | +$22.8M | 1.9% |
| Arrivent Biopharma Inc | New | +885,916 | +$20.4M | 1.7% |
| Soleno Therapeutics Inc | Trimmed | −600,000 | −$20.1M | 0.8% |
Showing the 10 largest of 31 changes.
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Verona Pharma PLC | Exited | −1,393,432 | −$149M | — |
| Cidara Therapeutics, Inc. | Trimmed | −354,755 | −$78.4M | 13.7% |
| Soleno Therapeutics Inc | Trimmed | −1,383,294 | −$64M | 2.7% |
| Terns Pharmaceuticals Inc | Trimmed | −1,548,818 | −$62.6M | 14.0% |
| Praxis Precision Medicines | Added | +130,000 | +$38.3M | 6.3% |
| Tourmaline Bio Inc. | Exited | −591,882 | −$28.3M | — |
| DT Dbv Technologies Sa | Added | +1,407,120 | +$27M | 3.1% |
| Olema Pharmaceuticals Inc | Trimmed | −834,019 | −$20.9M | 1.1% |
| Akero Therapeutics Inc | Exited | −434,689 | −$20.6M | — |
| Rezolute Inc | Exited | −2,112,432 | −$19.9M | — |
Showing the 10 largest of 27 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Soleno Therapeutics Inc | Trimmed | −1,680,091 | −$114M | 12.4% |
| AS Abivax Sa - ADR | New | +359,305 | +$30.5M | 2.5% |
| Cogent Biosciences Inc | Added | +1,666,666 | +$23.9M | 3.2% |
| Sab Biotherapeutics Inc | New | +11,420,000 | +$23M | 1.8% |
| Dyne Therapeutics Inc | Added | +1,500,000 | +$19M | 2.7% |
| Bright Minds Biosciences Inc | Added | +250,045 | +$15.2M | 2.4% |
| Dianthus Therapeutics Inc | New | +353,998 | +$13.9M | 1.1% |
| Lb Pharmaceuticals Inc | New | +800,000 | +$12.6M | 1.0% |
| Compass Therapeutics Inc | Added | +3,502,000 | +$12.3M | 2.7% |
| Camp4 Therapeutics Inc | New | +3,921,568 | +$11.8M | 0.9% |
Showing the 10 largest of 23 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Soleno Therapeutics Inc | Trimmed | −500,000 | −$41.9M | 33.9% |
| SB Sinovac Biotech Ltd. | New | +5,903,000 | +$38.2M | 3.9% |
| Cidara Therapeutics, Inc. | Added | +627,149 | +$30.5M | 6.5% |
| Cytomx Therapeutics Inc | New | +5,769,230 | +$13.1M | 1.3% |
| Akero Therapeutics Inc | Added | +233,521 | +$12.5M | 2.4% |
| Oric Pharmaceuticals Inc | Added | +1,046,154 | +$10.6M | 3.2% |
| DT Dbv Technologies Sa | New | +1,054,506 | +$9.66M | 1.0% |
| Praxis Precision Medicines | New | +167,600 | +$7.05M | 0.7% |
| Unicycive Therapeutics | Exited | −11,370,152 | −$6.54M | — |
| Compass Therapeutics Inc | Added | +2,487,443 | +$6.47M | 1.6% |
Showing the 10 largest of 21 changes.
quarter ended March 31, 2025 · filed May 12, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Soleno Therapeutics Inc | Trimmed | −1,833,557 | −$131M | 42.2% |
| Verona Pharma PLC | Trimmed | −845,190 | −$53.7M | 12.1% |
| Delcath Systems, Inc. | Trimmed | −958,384 | −$12.2M | 1.3% |
| Akero Therapeutics Inc | New | +201,168 | +$8.14M | 1.1% |
| CP Compass Pathway PLC | Added | +1,754,385 | +$5.02M | 1.3% |
| Oric Pharmaceuticals Inc | Added | +802,632 | +$4.48M | 1.5% |
| Regulus Therapeutics Inc | Trimmed | −2,303,574 | −$4.03M | 0.6% |
| Surrozen Inc | New | +260,000 | +$3.03M | 0.4% |
| 89bio Inc | New | +376,804 | +$2.74M | 0.4% |
| Rezolute Inc | Trimmed | −685,272 | −$1.99M | 0.8% |
Showing the 10 largest of 17 changes.
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Harmony Biosciences Holdings Inc | Exited | −2,606,247 | −$104M | — |
| SB Sinovac Biotech Ltd. | Exited | −11,800,000 | −$76.3M | — |
| Verona Pharma PLC | Trimmed | −1,265,783 | −$58.8M | 11.9% |
| Aclaris Therapeutics, Inc. | New | +8,888,888 | +$22M | 2.5% |
| Cidara Therapeutics, Inc. | New | +670,600 | +$18M | 2.0% |
| VT Viridian Therapeutics Inc | Trimmed | −695,631 | −$13.3M | 2.1% |
| Bright Minds Biosciences Inc | New | +251,572 | +$9.06M | 1.0% |
| Delcath Systems, Inc. | Added | +711,574 | +$8.57M | 2.3% |
| Trevi Therapeutics Inc | Added | +1,875,000 | +$7.73M | 1.6% |
| Alx Oncology Holdings Inc | Exited | −4,034,522 | −$7.34M | — |
Showing the 10 largest of 18 changes.
Loading...